乳房切除术后即刻重建后调强质子治疗的初步重建结局与并发症预测因素
本研究纳入2015至2017年51例接受假体即刻乳房重建后行乳房切除术后调强质子治疗(IMPT)的乳腺癌患者,前瞻性收集临床特征、剂量学与急性毒性,回顾性分析重建并发症。IMPT对心脏和肺的剂量较低且急性毒性低,但照射侧重建并发症更常见,大分割放疗与重建失败相关。
要点
- IMPT后急性皮炎以1级为主,心脏平均剂量低。
- 照射侧手术部位感染和计划外手术干预风险更高。
- 大分割放疗与照射侧重建失败风险升高相关。
核心结论
- 即刻乳房重建后行IMPT可保护心脏和肺,急性毒性低。
- 照射侧重建并发症更常见,重建结局与光子文献相当。
- 大分割放疗与更高的重建失败率相关,需进一步研究最佳剂量分割。
研究设计与样本
- 连续纳入接受假体即刻乳房重建和乳房切除术后IMPT的乳腺癌女性。
- 共51例患者,2015至2017年治疗,42例为双侧重建而单侧IMPT。
- 前瞻性收集临床特征、剂量学和急性毒性,回顾性收集重建并发症。
主要发现
- 37例(73%)接受常规分割(中位50 Gy/25次),14例(27%)接受大分割(中位40.5 Gy/15次)。
- 心脏平均剂量、同侧肺V20Gy和CTV-IMN V95%的中位数分别为0.6 Gy、13.9%和97.4%。
- 急性皮炎最大分级为1级32例(63%)、2级17例(33%)、3级2例(4%)。
- 照射侧手术部位感染(HR 13.19,95%CI 1.67-104.03,p=0.0012)和计划外手术干预(HR 9.86,95%CI 1.24-78.67,p=0.0068)更常见。
- 51例照射侧中8例和42例非照射侧中2例发生重建失败(HR 3.59,95%CI 0.78-16.41,p=0.084)。
关键数值与推荐
- 照射侧重建失败与大分割放疗相关(HR 4.99,95%CI 1.24-20.05,p=0.024)。
- 照射侧重建失败与患者年龄较大相关(HR 1.14,95%CI 1.05-1.24,p=0.002)。
临床怎么用
- IMPT可用于即刻乳房重建后放疗,以降低心脏和肺剂量及急性毒性。
- 照射侧需关注手术部位感染和计划外手术干预风险。
- 选择大分割放疗时应权衡重建失败风险,尤其对年龄较大患者。
局限性
- 回顾性收集重建并发症。
- 非随机对照设计,非照射侧作为对照。
- 样本量有限,重建失败事件数较少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To report reconstructive outcomes of patients treated with post-mastectomy intensity modulated proton therapy (IMPT) following immediate breast reconstruction (IBR). MATERIALS AND METHODS: Consecutive women with breast cancer who underwent implant-based IBR and post-mastectomy IMPT were included. Clinical characteristics, dosimetry, and acute toxicity were collected prospectively and reconstruction complications retrospectively. RESULTS: Fifty-one women were treated between 2015 and 2017. Forty-two had bilateral reconstruction with unilateral IMPT. The non-irradiated contralateral breasts served as controls. Conventional fractionation (median 50 Gy/25 fractions) was administered in 37 (73%) and hypofractionation (median 40.5 Gy/15 fractions) in 14 (27%) patients. Median mean heart, ipsilateral lung V20Gy, and CTV-IMN V95% were 0.6 Gy, 13.9%, and 97.4%. Maximal acute dermatitis grade was 1 in 32 (63%), 2 in 17 (33%), and 3 in 2 (4%) patients. Surgical site infection (hazard ratio [HR] 13.19, 95% confidence interval [CI] 1.67-104.03, p = 0.0012), and unplanned surgical intervention (HR 9.86, 95% CI 1.24-78.67, p = 0.0068) were more common in irradiated breasts. Eight of 51 irradiated breasts and 2 of 42 non-irradiated breasts had reconstruction failure (HR 3.59, 95% CI 0.78-16.41, p = 0.084). Among irradiated breasts, hypofractionation was significantly associated with reconstruction failure (HR 4.99, 95% CI 1.24-20.05, p = 0.024), as was older patient age (HR 1.14, 95% CI 1.05-1.24, p = 0.002). CONCLUSIONS: IMPT following IBR spared underlying organs and had low rates of acute toxicity. Reconstruction complications are more common in irradiated breasts, and reconstructive outcomes appear comparable with photon literature. Hypofractionation was associated with higher reconstruction failure rates. Further investigation of optimal dose-fractionation after IBR is needed.
引用
- Smith NL, Jethwa KR, Viehman JK, et al. Post-mastectomy intensity modulated proton therapy after immediate breast reconstruction: Initial report of reconstruction outcomes and predictors of complications. Radiother Oncol. 2019. PMID: 31185327. doi:10.1016/j.radonc.2019.05.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。